These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29949213)

  • 1. The therapeutic potential of kratom.
    Grundmann O; Brown PN; Henningfield J; Swogger M; Walsh Z
    Addiction; 2018 Oct; 113(10):1951-1953. PubMed ID: 29949213
    [No Abstract]   [Full Text] [Related]  

  • 2. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kratom policy: The challenge of balancing therapeutic potential with public safety.
    Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
    Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom & Stimulant Co-Addiction: A Case Series and Brief Review.
    Sablaban IM; Gautam M
    J Addict Dis; 2023; 41(2):181-184. PubMed ID: 35441584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kratom (Mitragyna speciosa): worldwide issues.
    Ramanathan S; McCurdy CR
    Curr Opin Psychiatry; 2020 Jul; 33(4):312-318. PubMed ID: 32452943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).
    Hartley C; Bulloch M; Penzak SR
    J Clin Pharmacol; 2022 May; 62(5):577-593. PubMed ID: 34775626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
    Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
    Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kratom: A growing substance of abuse in the United States.
    Demick DS; Lee TT; Summers AT; El-Mallakh RS
    Ann Clin Psychiatry; 2020 Nov; 32(4):275-280. PubMed ID: 32722734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.
    Anwar M; Law R; Schier J
    MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(29):748-9. PubMed ID: 27466822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    Prozialeck WC; Jivan JK; Andurkar SV
    J Am Osteopath Assoc; 2012 Dec; 112(12):792-9. PubMed ID: 23212430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kratom exposures reported to United States poison control centers: 2011-2017.
    Post S; Spiller HA; Chounthirath T; Smith GA
    Clin Toxicol (Phila); 2019 Oct; 57(10):847-854. PubMed ID: 30786220
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on the Pharmacology and Legal Status of Kratom.
    Prozialeck WC
    J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Scheduling of Kratom and Selective Use of Data.
    Griffin OH; Webb ME
    J Psychoactive Drugs; 2018; 50(2):114-120. PubMed ID: 28937941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use.
    Singh D; Narayanan S; Müller CP; Vicknasingam B; Yücel M; Ho ETW; Hassan Z; Mansor SM
    J Psychoactive Drugs; 2019; 51(1):19-27. PubMed ID: 30556488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kratom (Mitragyna speciosa): A Case Review of Use Before and During Pregnancy.
    Faucher MA; Morillos S; Cordova P; McNeil-Santiel J; Onisko N; Adhikari EH; Nelson DB
    J Midwifery Womens Health; 2024; 69(1):144-149. PubMed ID: 37679866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kratom Use and Toxicities in the United States.
    Eggleston W; Stoppacher R; Suen K; Marraffa JM; Nelson LS
    Pharmacotherapy; 2019 Jul; 39(7):775-777. PubMed ID: 31099038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.
    Buresh M
    J Addict Med; 2018; 12(6):481-483. PubMed ID: 29944481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations.
    McCurdy CR; Sharma A; Smith KE; Veltri CA; Weiss ST; White CM; Grundmann O
    Expert Rev Clin Pharmacol; 2024; 17(2):131-142. PubMed ID: 38217374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.